EXPAND AND CONSOLIDATE GLOBAL FOOTPRINT

to provide access to quality medicines at an affordable price

Konw More

About IMSDA

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Konw More

In The News

CDSCO Flags 280 Drug Batches Substandard in August 2026 Sweep - India’s Central Drugs Standard Control Organisation (CDSCO) has flagged approximately 280 drug batches as Not of Standard Quality (NSQ) in its latest quality surveillance sweep, according to reports in The Economic Times (August 21, 2026). The finding underscores the regulator’s ongoing post-market quality monitoring efforts across India’s pharmaceutical manufacturing landscape. 📊 What the CDSCO Quality […]
CDSCO Waives Phase 3 Trials for Generic Lenacapavir HIV Drug - The Central Drugs Standard Control Organisation (CDSCO) has waived the requirement for local Phase 3 clinical trials for generic versions of lenacapavir, a breakthrough HIV prevention drug, moving India significantly closer to affordable long-acting HIV pre-exposure prophylaxis (PrEP). As reported by ThePrint on August 25, 2026, this regulatory waiver is expected to accelerate the availability […]
Indian Pharma’s $250B 2030 Dream Threatened by Tariffs, Regulation - India’s pharmaceutical industry has set its sights on a $250 billion export target by 2030 — but according to Reuters, the sector is on track to miss that goal, squeezed by U.S. tariffs and persistent regulatory capacity gaps. The warning, delivered by India’s drug industry trade body, underscores the structural headwinds facing the country that […]
CDSCO Staffing Gap Threatens India’s Pharma Export Ambitions - India wants to be the “pharmacy of the world” — a $250 billion pharmaceutical export powerhouse supplying affordable generics to every corner of the globe. But a single structural problem stands in the way: the country’s drug regulator doesn’t have enough people to do the job. The Regulatory Capacity Constraint As Business Standard reported on […]
Read More

Our Videos

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Konw More

Stay Connected

If you have any question,please connect us.

Connect Us

Join Us

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Join Us